Pfizer Vaccine Provides Stronger Antibody Response than Sinovac: Study

New Delhi: People who took Pfizer’s Covid-19 vaccine were found to have “substantially higher” levels of antibodies than those who received Sinovac’s vaccine, the South China Morning Post reported, citing a study led by the University of Hong Kong (HKU).

Those who received the Sinovac vaccine may require a third booster shot as well, the study revealed.

The study aimed at tracking the antibody responses of 1,000 people who received either vaccine, the report said.

Comments are closed.